IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RONCA, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.600
EU - Europa 6.037
AS - Asia 4.873
SA - Sud America 815
AF - Africa 130
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 11
Totale 21.506
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.401
PL - Polonia 2.553
SG - Singapore 1.648
CN - Cina 1.550
IT - Italia 703
DE - Germania 696
UA - Ucraina 662
BR - Brasile 647
HK - Hong Kong 516
VN - Vietnam 401
FI - Finlandia 336
GB - Regno Unito 235
FR - Francia 214
RU - Federazione Russa 171
TR - Turchia 166
IN - India 164
IE - Irlanda 139
CA - Canada 114
BD - Bangladesh 77
AR - Argentina 60
NL - Olanda 60
ID - Indonesia 58
SE - Svezia 53
ZA - Sudafrica 51
JP - Giappone 48
MX - Messico 44
ES - Italia 40
CZ - Repubblica Ceca 39
AU - Australia 36
BE - Belgio 34
IQ - Iraq 31
PK - Pakistan 24
CL - Cile 23
EC - Ecuador 23
AT - Austria 22
IR - Iran 18
TW - Taiwan 18
CO - Colombia 17
SA - Arabia Saudita 17
MA - Marocco 16
NG - Nigeria 14
VE - Venezuela 14
AZ - Azerbaigian 13
PH - Filippine 13
CH - Svizzera 12
JO - Giordania 12
KR - Corea 11
LT - Lituania 11
PE - Perù 11
PY - Paraguay 11
TH - Thailandia 11
KE - Kenya 10
NO - Norvegia 10
TN - Tunisia 10
UZ - Uzbekistan 10
EU - Europa 9
IL - Israele 9
JM - Giamaica 9
AE - Emirati Arabi Uniti 8
BG - Bulgaria 8
LK - Sri Lanka 8
MY - Malesia 8
CR - Costa Rica 7
EG - Egitto 7
ET - Etiopia 7
MU - Mauritius 6
UY - Uruguay 6
GR - Grecia 5
GE - Georgia 4
HR - Croazia 4
KZ - Kazakistan 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
AW - Aruba 3
BO - Bolivia 3
BY - Bielorussia 3
CY - Cipro 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HN - Honduras 3
KH - Cambogia 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
RO - Romania 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
GD - Grenada 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
Totale 21.483
Salva come PNG Salva come JPEG
Città #
Warsaw 2.545
Fairfield 1.066
Ashburn 1.033
Singapore 956
Woodbridge 670
Hong Kong 507
Jacksonville 495
Houston 486
Seattle 413
Cambridge 412
San Jose 383
Ann Arbor 348
Chandler 347
Beijing 333
Wilmington 333
The Dalles 313
Brescia 299
Princeton 237
Helsinki 223
Los Angeles 221
New York 211
Nanjing 152
Munich 149
Dublin 133
Lauterbourg 131
Istanbul 129
Council Bluffs 124
Dearborn 123
Ho Chi Minh City 115
Dong Ket 90
San Francisco 83
Dallas 80
Shanghai 80
Milan 74
São Paulo 70
Chicago 69
Orem 68
Buffalo 67
Des Moines 66
Hanoi 65
Moscow 58
Redondo Beach 54
Changsha 48
Jakarta 48
Nanchang 48
Santa Clara 46
Shenyang 46
San Diego 42
Hebei 40
Phoenix 39
Tokyo 39
Montreal 38
Hangzhou 37
Jinan 36
London 36
Toronto 35
Chennai 33
Frankfurt am Main 33
Brussels 32
Lancaster 32
Tianjin 32
Stockholm 31
Brooklyn 30
Turku 30
Brno 27
Atlanta 26
Johannesburg 26
Amsterdam 24
Denver 23
Guangzhou 23
Lappeenranta 22
Rome 22
Boardman 20
Nuremberg 20
Kunming 19
Rio de Janeiro 18
Belo Horizonte 17
Boston 17
Melbourne 17
Mumbai 17
Ningbo 16
Taizhou 16
Haiphong 15
Verona 15
Washington 15
Falkenstein 14
Manchester 14
Poplar 14
Porto Alegre 14
San Mateo 14
Abuja 13
Baku 13
Jiaxing 13
Zhengzhou 13
Amman 12
Dhaka 12
Haikou 12
Hefei 12
New Taipei City 12
Ankara 11
Totale 15.250
Salva come PNG Salva come JPEG
Nome #
Tumor angiogenesis revisited: Regulators and clinical implications 411
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 372
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 347
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 341
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 311
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 301
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 299
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 287
Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics. 285
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 281
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 279
Caveolin-1 overexpression in the human embryonal rhabdomyosarcoma RD cells increases tumor growth and metastasis in vivo through a phospho-ERK-dependent signaling pathway 270
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 267
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 264
Caveolin-1 overexpression accelerates tumor growth and metastasis of embryonal rhabdomyosarcoma 259
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 256
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 254
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 246
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 224
Embryonic Stem Cells as a Model System to Elucidate Early Events in Cardiac Specification and Determination 221
Stromal delivery of long Pentraxin-3 impairsFGF7FGFR-dependent tumor growth and metastasis 220
Long pentraxin-3 follows and modulates bladder cancer progression 218
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 212
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 212
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 204
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 204
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 199
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 198
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 196
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation 192
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 189
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 189
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 188
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 187
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 185
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation 185
Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis 183
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 183
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation. 182
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 181
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors 181
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 178
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 175
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 175
Synthesis, in vitro and in vivo biological evaluation of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones as new potent anticancer agents 174
Beta-Galactosylceramidase deficiency: neurovascular implications 173
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 172
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 170
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome 170
Evaluating the effects of fluorine on biological properties and metabolic stability of some antitubulin 3-substituted 7-phenyl-pyrroloquinolinones 168
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 167
Circulating microRNAs and Their Role in Multiple Myeloma 167
Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors 167
Long pentraxin 3: A novel multifaceted player in cancer 167
Long pentraxin-3 modulates the angiogenic activity of fibroblast growth factor-2 162
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 159
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 158
Future applications of FGF/FGFR inhibitors in cancer 152
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 148
Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies 148
Design, Synthesis, in Vitro and in Vivo Anticancer and Antiangiogenic Activity of Novel 3-Arylamino Benzofuran Derivatives Targeting the Colchicine Site on Tubulin 146
Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors. 144
Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor β signalling pathway 144
Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes 144
Vascular disrupting activity of combretastatin analogues 144
Ten Years of CRISPRing Cancers In Vitro 143
The autocrine fgf/fgfr system in both skin and uveal melanoma: Fgf trapping as a possible therapeutic approach 142
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 141
Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. 140
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 139
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer 137
Heparin derivatives as angiogenesis inhibitors 136
Uptake Profiles of Human Serum Exosomes by Murine and Human Tumor Cells through Combined Use of Colloidal Nanoplasmonics and Flow Cytofluorimetric Analysis 134
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development. 132
Krabbe Disease and zebrafish: key-role of galactocerebrosidase in CNS development 130
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity 129
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress 128
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 128
Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice 121
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer 119
An embryonic stem cell perspective for FGFR1 signaling in cardiovascular development 119
Halting the FGF/FGFR axis leads to anti-tumor activity in Waldenström's Macroglobulinemia by silencing MYD88 119
An orthotopic model of uveal melanoma in zebrafish embryo: A novel platform for drug evaluation 119
FGF Ligand Traps for the Therapy of FGF-Dependent Tumors 118
Stromal expression of long Pentraxin-3 impairs tumor growth and metastasis 114
HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies 114
The zebrafish knockdown of galactocerebrosidase contributes to understand the human Krabbe Disease 112
Choline kinase alpha inhibition by EB-3D triggers cellular senescence, reduces tumor growth and metastatic dissemination in breast cancer 111
Isolation and characterization of neutralizing anti-FGFR1 single chain antibodies 110
Targeting FGF/FGFR1 system for an integrated anti-tumor/anti-angiogenic therapy of cancer 109
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma 109
FGFR-1 as an anti-angiogenic/anti-tumor target for squamous cell lung cancer therapy. 107
Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines 107
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 106
Heparin derivatives and semysynthetic biotechnological heparins as angiogenesis inhibitors 105
Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells 105
Fibroblast growth factor receptor-1 and cardiomyocyte development in murine embryonic stem cells 105
PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma 105
Glyco-Coated CdSe/ZnS Quantum Dots as Nanoprobes for Carbonic Anhydrase IX Imaging in Cancer Cells 103
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer 102
Totale 17.933
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.502
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021639 0 0 0 0 0 0 0 0 0 247 238 154
2021/20221.124 88 199 47 27 19 53 73 74 45 116 100 283
2022/20231.027 175 32 57 56 99 241 6 90 145 4 64 58
2023/20241.263 76 30 136 54 48 207 52 73 260 63 56 208
2024/20252.929 34 40 43 445 240 268 250 160 373 210 488 378
2025/20266.104 607 706 415 836 750 482 1.046 312 421 529 0 0
Totale 21.877